Phil Gold

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Dcirovic (talk | contribs) at 18:24, 5 May 2016 (Reverted edits by 142.134.201.85 (talk) (HG) (3.1.20)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Phil Gold
Born (1936-09-17) September 17, 1936 (age 87)
Alma materMcGill University
AwardsOrder of Canada
National Order of Quebec

Dr Phil Gold, CC OQ FRSC FRCPC (born September 17, 1936) is a Canadian physician, scientist, and professor.

Born in Montreal, Quebec, he received a B.Sc. degree in 1957, a M.Sc. degree in 1961, a M.D. degree in 1961, and a Ph.D. in 1965 from McGill University.

In 1968, he co-discovered with Samuel O. Freedman the carcinoembryonic antigen (CEA), which resulted in a blood test used in the diagnosis and management of people with cancer.

He is the Douglas G. Cameron Professor of Medicine, and Professor of Physiology and Oncology, at McGill University. He was Chairman of the Department of Medicine at McGill and Physician-in-Chief at the Montreal General Hospital.

In 1978, he was made an Officer of the Order of Canada and promoted to Companion in 1985.[1] In 1989, he was made an Officer of the National Order of Quebec. In 1977, he was made a Fellow of the Royal Society of Canada. In 1978, he was awarded the Gairdner Foundation International Award, awarded to three to six people for outstanding discoveries or contributions to medical science. He was awarded the Queen Elizabeth II Silver Jubilee Medal and the 125th Anniversary of the Confederation of Canada Medal. On April 13, 2010, he was inducted into the Canadian Medical Hall of Fame.

Honours

References